25 XP   0   0   10

Redhill Biopharma Ltd
Buy, Hold or Sell?

Let's analyse Redhill Biopharma Ltd together

PenkeI guess you are interested in Redhill Biopharma Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Redhill Biopharma Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Redhill Biopharma Ltd

I send you an email if I find something interesting about Redhill Biopharma Ltd.

Quick analysis of Redhill Biopharma Ltd (30 sec.)










What can you expect buying and holding a share of Redhill Biopharma Ltd? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.07
Expected worth in 1 year
$6.87
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$6.80
Return On Investment
1,615.1%

For what price can you sell your share?

Current Price per Share
$0.42
Expected price per share
$0.3057 - $0.6492
How sure are you?
50%

1. Valuation of Redhill Biopharma Ltd (5 min.)




Live pricePrice per Share (EOD)

$0.42

Intrinsic Value Per Share

$-16.93 - $21.60

Total Value Per Share

$-16.86 - $21.66

2. Growth of Redhill Biopharma Ltd (5 min.)




Is Redhill Biopharma Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$2m-$48.4m$50.4m2,439.3%

How much money is Redhill Biopharma Ltd making?

Current yearPrevious yearGrowGrow %
Making money$23.8m-$59.2m$83m348.4%
Net Profit Margin366.2%-95.9%--

How much money comes from the company's main activities?

3. Financial Health of Redhill Biopharma Ltd (5 min.)




What can you expect buying and holding a share of Redhill Biopharma Ltd? (5 min.)

Welcome investor! Redhill Biopharma Ltd's management wants to use your money to grow the business. In return you get a share of Redhill Biopharma Ltd.

What can you expect buying and holding a share of Redhill Biopharma Ltd?

First you should know what it really means to hold a share of Redhill Biopharma Ltd. And how you can make/lose money.

Speculation

The Price per Share of Redhill Biopharma Ltd is $0.4208. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Redhill Biopharma Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Redhill Biopharma Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.07. Based on the TTM, the Book Value Change Per Share is $1.70 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.93 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Redhill Biopharma Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.80190.8%0.80190.8%-1.99-474.0%-1.69-402.6%-1.34-317.7%
Usd Book Value Change Per Share1.70403.8%1.70403.8%-1.93-458.2%-0.33-78.6%-0.03-7.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.70403.8%1.70403.8%-1.93-458.2%-0.33-78.6%-0.03-7.9%
Usd Price Per Share1.46-1.46-0.14-3.67-6.57-
Price to Earnings Ratio1.82-1.82--0.07--1.29--7.97-
Price-to-Total Gains Ratio0.86-0.86--0.07-0.14-17.85-
Price to Book Ratio20.96-20.96--0.09-9.96-8.36-
Price-to-Total Gains Ratio0.86-0.86--0.07-0.14-17.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.4208
Number of shares2376
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.70-0.33
Usd Total Gains Per Share1.70-0.33
Gains per Quarter (2376 shares)4,037.11-785.79
Gains per Year (2376 shares)16,148.45-3,143.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1016148161380-3143-3153
2032297322860-6286-6296
3048445484340-9430-9439
4064594645820-12573-12582
5080742807300-15716-15725
6096891968780-18859-18868
701130391130260-22002-22011
801291881291740-25145-25154
901453361453220-28289-28297
1001614851614700-31432-31440

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%1.09.00.010.0%1.013.00.07.1%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%8.06.00.057.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.014.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%8.06.00.057.1%

Fundamentals of Redhill Biopharma Ltd

About Redhill Biopharma Ltd

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; and RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.

Fundamental data was last updated by Penke on 2024-04-12 16:23:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Redhill Biopharma Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Redhill Biopharma Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Redhill Biopharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 366.2% means that $3.66 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Redhill Biopharma Ltd:

  • The MRQ is 366.2%. The company is making a huge profit. +2
  • The TTM is 366.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ366.2%TTM366.2%0.0%
TTM366.2%YOY-95.9%+462.1%
TTM366.2%5Y-139.0%+505.2%
5Y-139.0%10Y-73,452.8%+73,313.8%
1.1.2. Return on Assets

Shows how efficient Redhill Biopharma Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Redhill Biopharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 103.5% Return on Assets means that Redhill Biopharma Ltd generated $1.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Redhill Biopharma Ltd:

  • The MRQ is 103.5%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 103.5%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ103.5%TTM103.5%0.0%
TTM103.5%YOY-37.3%+140.8%
TTM103.5%5Y-21.0%+124.5%
5Y-21.0%10Y-35.5%+14.5%
1.1.3. Return on Equity

Shows how efficient Redhill Biopharma Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Redhill Biopharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1,152.9% Return on Equity means Redhill Biopharma Ltd generated $11.53 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Redhill Biopharma Ltd:

  • The MRQ is 1,152.9%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 1,152.9%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ1,152.9%TTM1,152.9%0.0%
TTM1,152.9%YOY-+1,152.9%
TTM1,152.9%5Y-170.0%+1,322.9%
5Y-170.0%10Y-115.2%-54.8%

1.2. Operating Efficiency of Redhill Biopharma Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Redhill Biopharma Ltd is operating .

  • Measures how much profit Redhill Biopharma Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Redhill Biopharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -481.3% means the company generated $-4.81  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Redhill Biopharma Ltd:

  • The MRQ is -481.3%. The company is operating very inefficient. -2
  • The TTM is -481.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-481.3%TTM-481.3%0.0%
TTM-481.3%YOY-69.3%-412.0%
TTM-481.3%5Y-286.2%-195.2%
5Y-286.2%10Y-72,781.6%+72,495.5%
1.2.2. Operating Ratio

Measures how efficient Redhill Biopharma Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 5.81 means that the operating costs are $5.81 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Redhill Biopharma Ltd:

  • The MRQ is 5.813. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.813. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.813TTM5.8130.000
TTM5.813YOY1.693+4.120
TTM5.8135Y3.862+1.952
5Y3.86210Y1,531.631-1,527.770

1.3. Liquidity of Redhill Biopharma Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Redhill Biopharma Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.84 means the company has $0.84 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Redhill Biopharma Ltd:

  • The MRQ is 0.839. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.839. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.839TTM0.8390.000
TTM0.839YOY0.435+0.404
TTM0.8395Y1.669-0.830
5Y1.66910Y5.694-4.026
1.3.2. Quick Ratio

Measures if Redhill Biopharma Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Redhill Biopharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.50 means the company can pay off $0.50 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Redhill Biopharma Ltd:

  • The MRQ is 0.501. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.501. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.501TTM0.5010.000
TTM0.501YOY0.280+0.221
TTM0.5015Y1.791-1.290
5Y1.79110Y7.890-6.099

1.4. Solvency of Redhill Biopharma Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Redhill Biopharma Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Redhill Biopharma Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.91 means that Redhill Biopharma Ltd assets are financed with 91.0% credit (debt) and the remaining percentage (100% - 91.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Redhill Biopharma Ltd:

  • The MRQ is 0.910. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.910. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.910TTM0.9100.000
TTM0.910YOY1.305-0.394
TTM0.9105Y0.856+0.054
5Y0.85610Y0.506+0.350
1.4.2. Debt to Equity Ratio

Measures if Redhill Biopharma Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Redhill Biopharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 1,013.9% means that company has $10.14 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Redhill Biopharma Ltd:

  • The MRQ is 10.139. The company is unable to pay all its debts with equity. -1
  • The TTM is 10.139. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ10.139TTM10.1390.000
TTM10.139YOY-+10.139
TTM10.1395Y8.358+1.781
5Y8.35810Y4.273+4.085

2. Market Valuation of Redhill Biopharma Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Redhill Biopharma Ltd generates.

  • Above 15 is considered overpriced but always compare Redhill Biopharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 1.82 means the investor is paying $1.82 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Redhill Biopharma Ltd:

  • The EOD is 0.524. Based on the earnings, the company is cheap. +2
  • The MRQ is 1.818. Based on the earnings, the company is cheap. +2
  • The TTM is 1.818. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.524MRQ1.818-1.294
MRQ1.818TTM1.8180.000
TTM1.818YOY-0.070+1.888
TTM1.8185Y-1.290+3.108
5Y-1.29010Y-7.973+6.683
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Redhill Biopharma Ltd:

  • The EOD is -0.350. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.213. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.213. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.350MRQ-1.213+0.864
MRQ-1.213TTM-1.2130.000
TTM-1.213YOY-0.142-1.072
TTM-1.2135Y-1.856+0.642
5Y-1.85610Y-7.768+5.912
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Redhill Biopharma Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Redhill Biopharma Ltd:

  • The EOD is 6.041. Based on the equity, the company is overpriced. -1
  • The MRQ is 20.960. Based on the equity, the company is expensive. -2
  • The TTM is 20.960. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.041MRQ20.960-14.919
MRQ20.960TTM20.9600.000
TTM20.960YOY-0.086+21.046
TTM20.9605Y9.965+10.995
5Y9.96510Y8.359+1.606
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Redhill Biopharma Ltd.

3.1. Institutions holding Redhill Biopharma Ltd

Institutions are holding 6.702% of the shares of Redhill Biopharma Ltd.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Gagnon Securities LLC0.30160.0314895894162486.7799
2023-12-31JANE STREET GROUP, LLC0.2923086812868120
2023-09-30Citadel Advisors Llc0.187805577940050254.6252
2023-12-31Rhumbline Advisers0.11730.000134847318331056.1712
2023-12-31We Are One Seven, LLC0.0530.00131575000
2023-12-31Squarepoint Ops LLC0.0369010947109470
2023-12-31Group One Trading, LP0.0021061500
2023-12-31Morgan Stanley - Brokerage Accounts0.0019057617543.6409
2023-12-31Aspire Private Capital, LLC0.00140.00024054050
2023-12-31Steward Partners Investment Advisory, LLC0.0004012500
2023-12-31Citigroup Inc0.000401141140
2023-12-31Advisor Group Holdings, Inc.0.00040104-10-8.7719
2023-12-31UBS Group AG0.000401043346.4789
2023-12-31Bank of America Corp0.000308250156.25
2023-12-31Atlantic Edge Private Wealth Management LLC0.0001025250
2023-12-31Wells Fargo & Co0.000102300
2023-12-31JPMorgan Chase & Co00800
2023-12-31IFP Advisors, LLC00700
2023-09-30COWEN AND COMPANY, LLC000-288000-100
2023-12-31Virtu Financial LLC000-19865-100
Total 0.99640.033295912-95807-32.4%

3.2. Funds holding Redhill Biopharma Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Fidelity Nasdaq Composite Index0.00350104000
2024-03-31Yorkville Health Care Opportunities Cl F0.00120.003935900
Total 0.00470.0039139900.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Redhill Biopharma Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.6991.6990%-1.928+213%-0.331+119%-0.033+102%
Book Value Per Share--0.0700.0700%-1.629+2439%0.245-72%0.944-93%
Current Ratio--0.8390.8390%0.435+93%1.669-50%5.694-85%
Debt To Asset Ratio--0.9100.9100%1.305-30%0.856+6%0.506+80%
Debt To Equity Ratio--10.13910.1390%-+100%8.358+21%4.273+137%
Dividend Per Share----0%-0%-0%-0%
Eps--0.8030.8030%-1.995+348%-1.694+311%-1.337+266%
Free Cash Flow Per Share---1.203-1.2030%-0.989-18%-1.842+53%-1.398+16%
Free Cash Flow To Equity Per Share---0.483-0.4830%-0.604+25%-0.319-34%-0.022-96%
Gross Profit Margin--1.0001.0000%1.153-13%1.245-20%1.181-15%
Intrinsic Value_10Y_max--21.595--------
Intrinsic Value_10Y_min---16.928--------
Intrinsic Value_1Y_max---0.631--------
Intrinsic Value_1Y_min---1.824--------
Intrinsic Value_3Y_max--0.233--------
Intrinsic Value_3Y_min---5.402--------
Intrinsic Value_5Y_max--3.666--------
Intrinsic Value_5Y_min---8.867--------
Market Cap12499022.400-247%43366380.00043366380.0000%4167330.900+941%108892980.180-60%195119898.090-78%
Net Profit Margin--3.6623.6620%-0.959+126%-1.390+138%-734.528+20155%
Operating Margin---4.813-4.8130%-0.693-86%-2.862-41%-727.816+15020%
Operating Ratio--5.8135.8130%1.693+243%3.862+51%1531.631-100%
Pb Ratio6.041-247%20.96020.9600%-0.086+100%9.965+110%8.359+151%
Pe Ratio0.524-247%1.8181.8180%-0.070+104%-1.290+171%-7.973+539%
Price Per Share0.421-247%1.4601.4600%0.140+941%3.666-60%6.569-78%
Price To Free Cash Flow Ratio-0.350+71%-1.213-1.2130%-0.142-88%-1.856+53%-7.768+540%
Price To Total Gains Ratio0.248-247%0.8590.8590%-0.073+108%0.135+536%17.852-95%
Quick Ratio--0.5010.5010%0.280+79%1.791-72%7.890-94%
Return On Assets--1.0351.0350%-0.373+136%-0.210+120%-0.355+134%
Return On Equity--11.52911.5290%-+100%-1.700+115%-1.152+110%
Total Gains Per Share--1.6991.6990%-1.928+213%-0.331+119%-0.033+102%
Usd Book Value--2069012.0002069012.0000%-48400000.000+2439%7282002.400-72%28045001.200-93%
Usd Book Value Change Per Share--1.6991.6990%-1.928+213%-0.331+119%-0.033+102%
Usd Book Value Per Share--0.0700.0700%-1.629+2439%0.245-72%0.944-93%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.8030.8030%-1.995+348%-1.694+311%-1.337+266%
Usd Free Cash Flow---35738669.000-35738669.0000%-29383000.000-18%-54717733.800+53%-41523066.900+16%
Usd Free Cash Flow Per Share---1.203-1.2030%-0.989-18%-1.842+53%-1.398+16%
Usd Free Cash Flow To Equity Per Share---0.483-0.4830%-0.604+25%-0.319-34%-0.022-96%
Usd Market Cap12499022.400-247%43366380.00043366380.0000%4167330.900+941%108892980.180-60%195119898.090-78%
Usd Price Per Share0.421-247%1.4601.4600%0.140+941%3.666-60%6.569-78%
Usd Profit--23854372.00023854372.0000%-59245000.000+348%-56470525.600+337%-42788762.800+279%
Usd Revenue--6513173.0006513173.0000%61800000.000-89%44944034.600-86%24420517.300-73%
Usd Total Gains Per Share--1.6991.6990%-1.928+213%-0.331+119%-0.033+102%
 EOD+3 -5MRQTTM+0 -0YOY+23 -115Y+15 -1910Y+16 -18

4.2. Fundamental Score

Let's check the fundamental score of Redhill Biopharma Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.524
Price to Book Ratio (EOD)Between0-16.041
Net Profit Margin (MRQ)Greater than03.662
Operating Margin (MRQ)Greater than0-4.813
Quick Ratio (MRQ)Greater than10.501
Current Ratio (MRQ)Greater than10.839
Debt to Asset Ratio (MRQ)Less than10.910
Debt to Equity Ratio (MRQ)Less than110.139
Return on Equity (MRQ)Greater than0.1511.529
Return on Assets (MRQ)Greater than0.051.035
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Redhill Biopharma Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.352
Ma 20Greater thanMa 500.482
Ma 50Greater thanMa 1000.522
Ma 100Greater thanMa 2000.864
OpenGreater thanClose0.405
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Income before Tax  -42,304-33,869-76,173-21,571-97,74426,075-71,66995,52323,854
Net Income  -43,634-45,383-89,017-25,294-114,31155,066-59,24583,09923,854



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets23,047
Total Liabilities20,978
Total Stockholder Equity2,069
 As reported
Total Liabilities 20,978
Total Stockholder Equity+ 2,069
Total Assets = 23,047

Assets

Total Assets23,047
Total Current Assets16,140
Long-term Assets6,907
Total Current Assets
Cash And Cash Equivalents 6,359
Net Receivables 3,285
Inventory 5,699
Other Current Assets 797
Total Current Assets  (as reported)16,140
Total Current Assets  (calculated)16,140
+/- 0
Long-term Assets
Property Plant Equipment 1,182
Long-term Assets Other 5,578
Long-term Assets  (as reported)6,907
Long-term Assets  (calculated)6,760
+/- 147

Liabilities & Shareholders' Equity

Total Current Liabilities19,242
Long-term Liabilities1,736
Total Stockholder Equity2,069
Total Current Liabilities
Short-term Debt 718
Accounts payable 3,278
Other Current Liabilities 15,246
Total Current Liabilities  (as reported)19,242
Total Current Liabilities  (calculated)19,242
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)1,736
Long-term Liabilities  (calculated)0
+/- 1,736
Total Stockholder Equity
Common Stock21,441
Retained Earnings -407,737
Other Stockholders Equity 388,365
Total Stockholder Equity (as reported)2,069
Total Stockholder Equity (calculated)2,069
+/-0
Other
Cash and Short Term Investments 6,359
Common Stock Shares Outstanding 6,478
Current Deferred Revenue0
Liabilities and Stockholders Equity 23,047
Net Debt -5,186
Net Working Capital -3,102
Short Long Term Debt Total 1,173



Balance Sheet

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
> Total Assets 
10,510
20,186
20,096
14,340
28,856
66,828
74,212
57,343
62,411
74,099
180,241
181,188
158,870
23,047
23,047158,870181,188180,24174,09962,41157,34374,21266,82828,85614,34020,09620,18610,510
   > Total Current Assets 
0
18,736
18,563
12,601
26,019
60,510
67,815
51,676
56,788
53,214
70,495
89,152
85,900
16,140
16,14085,90089,15270,49553,21456,78851,67667,81560,51026,01912,60118,56318,7360
       Cash And Cash Equivalents 
9,050
14,070
16,814
11,851
5,892
21,516
53,786
16,455
29,005
29,023
29,295
29,474
19,968
6,359
6,35919,96829,47429,29529,02329,00516,45553,78621,5165,89211,85116,81414,0709,050
       Short-term Investments 
15
4,577
1,551
262
17,053
36,622
12,368
29,750
24,180
18,849
498
8,530
15
0
0158,53049818,84924,18029,75012,36836,62217,0532621,5514,57715
       Net Receivables 
0
19
84
427
1,064
220
492
1,528
958
1,216
28,655
32,524
35,352
3,285
3,28535,35232,52428,6551,2169581,5284922201,06442784190
       Inventory 
0
-1,494
-951
-366
-15,043
-34,470
1,114
653
769
1,882
6,526
14,810
11,009
5,699
5,69911,00914,8106,5261,8827696531,114-34,470-15,043-366-951-1,4940
   > Long-term Assets 
0
1,450
1,533
1,739
2,837
6,318
6,397
5,667
5,623
20,885
109,746
92,036
72,970
6,907
6,90772,97092,036109,74620,8855,6235,6676,3976,3182,8371,7391,5331,4500
       Property Plant Equipment 
8
132
113
103
146
124
165
230
163
3,806
5,703
4,223
7,194
1,182
1,1827,1944,2235,7033,8061632301651241461031131328
       Long Term Investments 
0
0
0
81
76
134
137
152
140
152
0
0
0
0
00001521401521371347681000
       Intangible Assets 
1,200
1,245
1,345
1,555
2,615
6,060
6,095
5,285
5,320
16,927
87,879
71,644
65,626
0
065,62671,64487,87916,9275,3205,2856,0956,0602,6151,5551,3451,2451,200
       Other Assets 
0
73
75
81
76
134
137
152
140
152
16,164
16,169
0
0
0016,16916,164152140152137134768175730
> Total Liabilities 
12,104
1,399
1,078
2,415
3,845
6,751
11,511
12,278
11,225
14,097
166,377
172,313
207,270
20,978
20,978207,270172,313166,37714,09711,22512,27811,5116,7513,8452,4151,0781,39912,104
   > Total Current Liabilities 
141
513
1,078
2,415
1,720
5,514
5,356
11,830
10,381
10,616
73,235
81,470
197,454
19,242
19,242197,45481,47073,23510,61610,38111,8305,3565,5141,7202,4151,078513141
       Short-term Debt 
0
0
0
0
0
0
0
0
0
834
1,710
1,618
116,248
718
718116,2481,6181,710834000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
115,216
0
0115,216000000000000
       Accounts payable 
3
337
313
882
1,720
3,514
3,356
4,805
3,324
4,184
11,553
11,664
4,230
3,278
3,2784,23011,66411,5534,1843,3244,8053,3563,5141,7208823133373
       Other Current Liabilities 
138
176
765
1,533
1,654
2,000
2,000
7,025
7,057
107
18,343
30,877
76,976
15,246
15,24676,97630,87718,3431077,0577,0252,0002,0001,6541,533765176138
   > Long-term Liabilities 
0
886
0
0
2,125
1,237
6,155
448
844
3,481
93,142
90,843
9,816
1,736
1,7369,81690,84393,1423,4818444486,1551,2372,125008860
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
2,981
3,807
2,574
-108,773
-718
-718-108,7732,5743,8072,981000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
500
500
750
750
750
0
075075075050050000000000
> Total Stockholder Equity
0
18,787
19,018
11,925
25,011
60,077
62,701
45,065
51,186
60,002
13,864
8,875
-48,400
2,069
2,069-48,4008,87513,86460,00251,18645,06562,70160,07725,01111,92519,01818,7870
   Retained Earnings -407,737-433,860-367,866-280,334-208,363-169,086-132,944-89,635-61,944-42,218-33,260-23,887-15,2090
   Accumulated Other Comprehensive Income 0000-444-341-251-170-126-90-63-39-150
   Capital Surplus 00000000000000
   Treasury Stock00000000000000



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue6,513
Cost of Revenue-3,450
Gross Profit3,0633,063
 
Operating Income (+$)
Gross Profit3,063
Operating Expense-34,414
Operating Income-31,351-31,351
 
Operating Expense (+$)
Research Development3,519
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense34,4143,519
 
Net Interest Income (+$)
Interest Income0
Interest Expense-427
Other Finance Cost-427
Net Interest Income0
 
Pretax Income (+$)
Operating Income-31,351
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)23,854-86,556
EBIT - interestExpense = -31,778
23,854
24,281
Interest Expense427
Earnings Before Interest and Taxes (EBIT)-31,35124,281
Earnings Before Interest and Taxes (EBITDA)-29,366
 
After tax Income (+$)
Income Before Tax23,854
Tax Provision-0
Net Income From Continuing Ops023,854
Net Income23,854
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses37,864
Total Other Income/Expenses Net55,2050
 

Technical Analysis of Redhill Biopharma Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Redhill Biopharma Ltd. The general trend of Redhill Biopharma Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Redhill Biopharma Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Redhill Biopharma Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.4531 < 0.5639 < 0.6492.

The bearish price targets are: 0.375 > 0.31 > 0.3057.

Tweet this
Redhill Biopharma Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Redhill Biopharma Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Redhill Biopharma Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Redhill Biopharma Ltd. The current macd is -0.04053126.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Redhill Biopharma Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Redhill Biopharma Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Redhill Biopharma Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Redhill Biopharma Ltd Daily Moving Average Convergence/Divergence (MACD) ChartRedhill Biopharma Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Redhill Biopharma Ltd. The current adx is 26.46.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Redhill Biopharma Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Redhill Biopharma Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Redhill Biopharma Ltd. The current sar is 0.44994753.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Redhill Biopharma Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Redhill Biopharma Ltd. The current rsi is 36.35. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Redhill Biopharma Ltd Daily Relative Strength Index (RSI) ChartRedhill Biopharma Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Redhill Biopharma Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Redhill Biopharma Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Redhill Biopharma Ltd Daily Stochastic Oscillator ChartRedhill Biopharma Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Redhill Biopharma Ltd. The current cci is -102.55374465.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Redhill Biopharma Ltd Daily Commodity Channel Index (CCI) ChartRedhill Biopharma Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Redhill Biopharma Ltd. The current cmo is -28.35036543.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Redhill Biopharma Ltd Daily Chande Momentum Oscillator (CMO) ChartRedhill Biopharma Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Redhill Biopharma Ltd. The current willr is -54.22508526.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Redhill Biopharma Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Redhill Biopharma Ltd Daily Williams %R ChartRedhill Biopharma Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Redhill Biopharma Ltd.

Redhill Biopharma Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Redhill Biopharma Ltd. The current atr is 0.04274405.

Redhill Biopharma Ltd Daily Average True Range (ATR) ChartRedhill Biopharma Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Redhill Biopharma Ltd. The current obv is 450,843,279.

Redhill Biopharma Ltd Daily On-Balance Volume (OBV) ChartRedhill Biopharma Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Redhill Biopharma Ltd. The current mfi is 30.53.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Redhill Biopharma Ltd Daily Money Flow Index (MFI) ChartRedhill Biopharma Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Redhill Biopharma Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside

6.3. Candlestick Patterns

Redhill Biopharma Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Redhill Biopharma Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.352
Ma 20Greater thanMa 500.482
Ma 50Greater thanMa 1000.522
Ma 100Greater thanMa 2000.864
OpenGreater thanClose0.405
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Redhill Biopharma Ltd with someone you think should read this too:
  • Are you bullish or bearish on Redhill Biopharma Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Redhill Biopharma Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Redhill Biopharma Ltd

I send you an email if I find something interesting about Redhill Biopharma Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Redhill Biopharma Ltd.

Receive notifications about Redhill Biopharma Ltd in your mailbox!